{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:07:15Z","timestamp":1789200435591,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Basic Research Plan Project of Yunnan Provincial Department of Science and Technology","award":["202201AY070001-123"],"award-info":[{"award-number":["202201AY070001-123"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s12010-026-05724-8","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T02:21:52Z","timestamp":1779675712000},"page":"6504-6520","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Impact of 125I Particle Implantation Therapy on Telomerase Activity and WNT5A\/\u03b2-catenin Signaling Pathway in Thyroid Cancer Cells"],"prefix":"10.1007","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7663-5793","authenticated-orcid":false,"given":"Zhi","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4739-1056","authenticated-orcid":false,"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8012-9136","authenticated-orcid":false,"given":"JunFeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7206-5618","authenticated-orcid":false,"given":"LiYing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7132-0189","authenticated-orcid":false,"given":"SiQi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"issue":"10387","key":"5724_CR1","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen, D. W., Lang, B. H. H., McLeod, D. S. A., Newbold, K., & Haymart, M. R. (2023). Thyroid cancer. Lancet, 401(10387), 1531\u20131544.","journal-title":"Lancet"},{"issue":"2","key":"5724_CR2","first-page":"251","volume":"24","author":"J Huang","year":"2022","unstructured":"Huang, J., Sun, Y., & Fang, X. (2022). Pathology and ultrasound findings in diffuse sclerosing thyroid papillary carcinoma. Medicina Ultrasonografica, 24(2), 251\u2013252.","journal-title":"Medicina Ultrasonografica"},{"issue":"1","key":"5724_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1186\/s12885-022-09643-9","volume":"22","author":"X Zou","year":"2022","unstructured":"Zou, X., Zhou, Q., Nie, Y., Gou, J., Yang, J., Zhu, J., et al. (2022). Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS\/ERK signaling pathway. BMC Cancer, 22(1), 595.","journal-title":"BMC Cancer"},{"issue":"5","key":"5724_CR4","doi-asserted-by":"publisher","first-page":"13201","DOI":"10.1080\/21655979.2022.2076498","volume":"13","author":"G Liao","year":"2022","unstructured":"Liao, G., Huang, Z., Gan, T., Wu, C., Wang, X., & Li, D. (2022). Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) modulates inhibitor of DNA binding 1 (ID1) to facilitate papillary thyroid carcinoma development by sponging microRNA-524-5p. Bioengineered, 13(5), 13201\u201313212.","journal-title":"Bioengineered"},{"issue":"8","key":"5724_CR5","doi-asserted-by":"publisher","first-page":"925","DOI":"10.6004\/jnccn.2022.0040","volume":"20","author":"RI Haddad","year":"2022","unstructured":"Haddad, R. I., Bischoff, L., Ball, D., Bernet, V., Blomain, E., Busaidy, N. L., et al. (2022). Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Journal Of The National Comprehensive Cancer Network, 20(8), 925\u2013951.","journal-title":"Journal Of The National Comprehensive Cancer Network"},{"issue":"12","key":"5724_CR6","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1089\/thy.2021.0307","volume":"31","author":"NS Huang","year":"2021","unstructured":"Huang, N. S., Wei, W. J., Xiang, J., Chen, J. Y., Guan, Q., Lu, Z. W., et al. (2021). The efficacy and safety of Anlotinib in neoadjuvant treatment of locally advanced thyroid cancer: A single-arm phase II clinical trial. Thyroid\u202f: Official Journal of the American Thyroid Association, 31(12), 1808\u201313.","journal-title":"Thyroid : Official Journal of the American Thyroid Association"},{"issue":"6","key":"5724_CR7","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.amjsurg.2023.01.009","volume":"225","author":"K Goodsell","year":"2023","unstructured":"Goodsell, K., Ermer, J., Amjad, W., Swisher-McClure, S., & Wachtel, H. (2023). External beam radiotherapy for thyroid cancer: Patients, complications, and survival. American Journal Of Surgery, 225(6), 994\u2013999.","journal-title":"American Journal Of Surgery"},{"issue":"10","key":"5724_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s13205-023-03759-w","volume":"13","author":"ARA Prasad","year":"2023","unstructured":"Prasad, A. R. A., Priya, K., Meena, R., & Ghosh, I. (2023). Effect of differential deprivation of nutrients on cellular proliferation, oxidative stress, mitochondrial function, and cell migration in MDA-MB-231, HepG2, and HeLa cells. 3 Biotech, 13(10), 339.","journal-title":"3 Biotech"},{"issue":"2","key":"5724_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jimed.2021.02.009","volume":"4","author":"F Zhang","year":"2021","unstructured":"Zhang, F., Zheng, L., Li, D., & Yang, H. (2021). To explore the curative effect of CT-guided iodine-125 radioactive seed implantation in the treatment of stage \u2163primary hepatocellular carcinoma. Journal of Interventional Medicine, 4(2), 82\u201386.","journal-title":"Journal of Interventional Medicine"},{"issue":"2","key":"5724_CR10","first-page":"121","volume":"1","author":"LS Li","year":"2018","unstructured":"Li, L. S. (2018). Further recognition of interventional medicine. Journal of Interventional Medicine, 1(2), 121\u2013123.","journal-title":"Journal of Interventional Medicine"},{"issue":"4","key":"5724_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jimed.2021.08.001","volume":"4","author":"M Li","year":"2021","unstructured":"Li, M. (2021). Clinical practice guidelines for the interventional treatment of advanced pancreatic cancer (5(th) edition). Journal of Interventional Medicine, 4(4), 159\u2013171.","journal-title":"Journal of Interventional Medicine"},{"key":"5724_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.717180","volume":"11","author":"SLC Wei","year":"2021","unstructured":"Wei, S. L. C., Li, M., Xiong, Y., Jiang, Y., Sun, H., Qiu, B., Lin, C. J., & Wang, J. (2021). Radioactive iodine-125 in tumor therapy: Advances and future directions. Frontiers in Oncology, 11, Article 717180.","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"5724_CR13","doi-asserted-by":"publisher","DOI":"10.36922\/arnm.0907","volume":"1","author":"SQB Tian","year":"2023","unstructured":"Tian, S. Q. B., Jiang, P., Jiang, Y., Ji, Z., Huang, M., & Wang, J. (2023). Image-guided permanent I-125 seed implantation for refractory head-and-neck carcinoma in China: A comprehensive review of contemporary technical and clinical aspects. Advances in Radiotherapy and Nuclear Medicine, 1(1), Article 0907.","journal-title":"Advances in Radiotherapy and Nuclear Medicine"},{"issue":"1","key":"5724_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.asjsur.2019.05.012","volume":"43","author":"LLCX Xie","year":"2020","unstructured":"Xie, L. L. C. X., Yang, C. Y., Yan, Z. L., Zhu, J., Quan, K. Q., & Pu, D. (2020). Efficacy and complications of 125I seeds combined with percutaneous vertebroplasty for metastatic spinal tumors: A literature review. Asian Journal Of Surgery \/ Asian Surgical Association, 43(1), 29\u201335.","journal-title":"Asian Journal Of Surgery \/ Asian Surgical Association"},{"key":"5724_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.738230","volume":"12","author":"GHT van de Kamp","year":"2021","unstructured":"van de Kamp, G. H. T., Kanaar, R., & Essers, J. (2021). DNA double-strand break repair pathways in response to different types of ionizing radiation. Frontiers in Genetics, 12, Article 738230.","journal-title":"Frontiers in Genetics"},{"issue":"7","key":"5724_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202002567","volume":"8","author":"SSR Peng","year":"2021","unstructured":"Peng, S. S. R., Lin, Q., Zhang, Y., Yang, Y., Luo, M., Zhong, Z., Xu, X., Lu, L., Yao, S., & Zhang, F. (2021). A robust oxygen microbubble radiosensitizer for iodine-125 brachytherapy. Advanced Science, 8(7), Article 2002567.","journal-title":"Advanced Science"},{"key":"5724_CR17","doi-asserted-by":"crossref","unstructured":"Yao, X. L. S., Feng, C., Suo, R., Li, H., Zhang, Y., Chen, Q., Lu, J., Wu, B., & Guo, J. (2022). Tumor oxygenation nanoliposome synergistic hypoxia-inducible-factor-1 inhibitor enhanced iodine-125 seed brachytherapy for esophageal cancer. Biomaterials, 121801.","DOI":"10.1016\/j.biomaterials.2022.121801"},{"issue":"1","key":"5724_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu, J., Xiao, Q., Xiao, J., Niu, C., Li, Y., Zhang, X., et al. (2022). Wnt\/beta-catenin signalling: Function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther, 7(1), 3.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"5724_CR19","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1007\/s11136-018-1928-y","volume":"27","author":"T Zhou","year":"2018","unstructured":"Zhou, T., Guan, H., Yao, J., Xiong, X., & Ma, A. (2018). The quality of life in Chinese population with chronic non-communicable diseases according to EQ-5D-3L: A systematic review. Quality of Life Research, 27(11), 2799\u20132814.","journal-title":"Quality of Life Research"},{"issue":"8","key":"5724_CR20","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/bjc.2012.81","volume":"106","author":"U Stein","year":"2012","unstructured":"Stein, U., Fleuter, C., Siegel, F., Smith, J., Kopacek, A., & Scudiero, D. A. (2012). Impact of mutant beta-catenin on ABCB1 expression and therapy response in colon cancer cells. British Journal of Cancer, 106(8), 1395\u2013405.","journal-title":"British Journal of Cancer"},{"issue":"1","key":"5724_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12967-025-06236-5","volume":"23","author":"YCY Lu","year":"2025","unstructured":"Lu, Y. C. Y., Wang, Z., Shen, H., Xu, L., Huang, C., Tong, Y., Shao, Y., Zhang, H., & Fu, Z. (2025). Single-cell and spatial transcriptome profiling reveal CTHRC1\u2009+\u2009fibroblasts promote EMT through WNT5A signaling in colorectal cancer. J Transl Med, 23(1), 282.","journal-title":"J Transl Med"},{"issue":"1","key":"5724_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pharmthera.2013.01.002","volume":"138","author":"HAKM Baarsma","year":"2013","unstructured":"Baarsma, H. A. K. M., & Gosens, R. (2013). The WNT signaling pathway from ligand secretion to gene transcription: Molecular mechanisms and pharmacological targets. Pharmacology & Therapeutics, 138(1), 66\u201383.","journal-title":"Pharmacology & Therapeutics"},{"issue":"7","key":"5724_CR23","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.cell.2007.12.011","volume":"131","author":"MVHR Semenov","year":"2007","unstructured":"Semenov, M. V. H. R., Macdonald, B. T., & He, X. (2007). SnapShot: Noncanonical Wnt signaling pathways. Cell, 131(7), 1378.","journal-title":"Cell"},{"issue":"2","key":"5724_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/sj.bjc.6605174","volume":"101","author":"SLSA McDonald","year":"2009","unstructured":"McDonald, S. L. S. A. (2009). The opposing roles of Wnt-5a in cancer. British Journal of Cancer, 101(2), 209\u2013214.","journal-title":"British Journal of Cancer"},{"issue":"5","key":"5724_CR25","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1074\/jbc.M508386200","volume":"281","author":"ALK S\u00e4fholm","year":"2006","unstructured":"S\u00e4fholm, A. L. K., Dejmek, J., Nielsen, C. K., Villoutreix, B. O., & Andersson, T. (2006). A formylated hexapeptide ligand mimics the ability of Wnt-5a to impair migration of human breast epithelial cells. Journal of Biological Chemistry, 281(5), 2740\u20132749.","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"5724_CR26","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1118\/1.1646040","volume":"31","author":"MJCB Rivard","year":"2004","unstructured":"Rivard, M. J. C. B., DeWerd, L. A., Hanson, W. F., Huq, M. S., Ibbott, G. S., Mitch, M. G., Nath, R., & Williamson, J. F. (2004). Update of AAPM Task Group 43 report: A revised AAPM protocol for brachytherapy dose calculations. Medical Physics, 31(3), 633\u2013674.","journal-title":"Medical Physics"},{"issue":"29","key":"5724_CR27","doi-asserted-by":"publisher","first-page":"10399","DOI":"10.1039\/D2NR02150A","volume":"14","author":"AKA Prasad","year":"2022","unstructured":"Prasad, A. K. A., Mohanta, Y. K., Saravanan, M., Meena, R., & Ghosh, I. (2022). Low-dose exposure to phytosynthesized gold nanoparticles combined with glutamine deprivation enhances cell death in the cancer cell line HeLa via oxidative stress-mediated mitochondrial dysfunction and G0\/G1 cell cycle arrest. Nanoscale, 14(29), 10399\u2013417.","journal-title":"Nanoscale"},{"issue":"11","key":"5724_CR28","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1002\/tox.24388","volume":"39","author":"KRA Priya","year":"2024","unstructured":"Priya, K. R. A., Prasad, A., Kumar, P., & Ghosh, I. (2024). Naringenin against Cadmium toxicity in fibroblast cells: An integrated network pharmacology and in vitro metabolomics approach. Environmental Toxicology, 39(11), 5124\u20135139.","journal-title":"Environmental Toxicology"},{"key":"5724_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.178167","volume":"1006","author":"N Gao","year":"2025","unstructured":"Gao, N., Han, J., Sun, X., Yu, J., Huang, J., Liu, R., Tang, Y. L., & Nie, C. (2025). Erianin induces apoptosis of thyroid cancer cells via TNF signaling pathway. European Journal of Pharmacology, 1006, Article 178167.","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"5724_CR30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7150\/ijbs.116651","volume":"22","author":"H Lim","year":"2026","unstructured":"Lim, H., Lee, S., Kim, G., Lee, E. J., & Kim, J. (2026). AVN944 elicits apoptotic responses and impedes tumorigenic potential in Ewing\u2019s sarcoma cells. International Journal of Biological Sciences, 22(2), 529\u2013552.","journal-title":"International Journal of Biological Sciences"},{"key":"5724_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2020.101860","volume":"70","author":"M Fridman","year":"2021","unstructured":"Fridman, M., Krasko, O., Levin, L., Veyalkin, I., & Lam, A. K. (2021). Second primary malignancies in patients with papillary thyroid carcinoma after effect of post-Chernobyl irradiation: A risk analysis of more than two decades of observations. Cancer Epidemiology, 70, Article 101860.","journal-title":"Cancer Epidemiology"},{"key":"5724_CR32","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/1748-717X-8-196","volume":"8","author":"H Wang","year":"2013","unstructured":"Wang, H., Li, J., Qu, A., Liu, J., Zhao, Y., & Wang, J. (2013). The different biological effects of single, fractionated and continuous low dose rate irradiation on CL187 colorectal cancer cells. Radiation Oncology, 8, 196.","journal-title":"Radiation Oncology"},{"key":"5724_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.922922","volume":"13","author":"Q Liao","year":"2022","unstructured":"Liao, Q., He, J., Tian, F. F., Bi, F. F., & Huang, K. (2022). A causal relationship between leukocyte telomere length and multiple sclerosis: A Mendelian randomization study. Frontiers in Immunology, 13, Article 922922.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"5724_CR34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00018-019-03369-x","volume":"77","author":"EM Smith","year":"2020","unstructured":"Smith, E. M., Pendlebury, D. F., & Nandakumar, J. (2020). Structural biology of telomeres and telomerase. Cellular And Molecular Life Sciences, 77(1), 61\u201379.","journal-title":"Cellular And Molecular Life Sciences"},{"key":"5724_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceb.2017.12.001","volume":"52","author":"JW Shay","year":"2018","unstructured":"Shay, J. W. (2018). Telomeres and aging. Current Opinion In Cell Biology, 52, 1\u20137.","journal-title":"Current Opinion In Cell Biology"},{"key":"5724_CR36","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3389\/fcell.2019.00332","volume":"7","author":"E S\u00e9gal-Bendirdjian","year":"2019","unstructured":"S\u00e9gal-Bendirdjian, E., & V, G. (2019). Non-canonical roles of telomerase: Unraveling the imbroglio. Frontiers In Cell And Developmental Biology, 7, 332.","journal-title":"Frontiers In Cell And Developmental Biology"},{"issue":"10","key":"5724_CR37","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s13238-014-0089-1","volume":"5","author":"S Xiong","year":"2014","unstructured":"Xiong, S., T, M., Wang, G., & Jiang, X. (2014). Mitochondria-mediated apoptosis in mammals. Protein & Cell, 5(10), 737\u201349.","journal-title":"Protein & Cell"},{"issue":"4","key":"5724_CR38","first-page":"1624","volume":"2","author":"P H","year":"2021","unstructured":"H, P. (2021). Apoptosis regulators Bcl-2 and Caspase-3. Encyclopedia, 2(4), 1624\u201336.","journal-title":"Encyclopedia"},{"issue":"6","key":"5724_CR39","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3390\/ijms20061509","volume":"20","author":"PDSN Green","year":"2019","unstructured":"Green, P. D. S. N., & Santos, J. H. (2019). Telomerase impinges on the cellular response to oxidative stress through mitochondrial ROS-mediated regulation of autophagy. International Journal Of Molecular Sciences, 20(6), 1509.","journal-title":"International Journal Of Molecular Sciences"},{"issue":"6","key":"5724_CR40","first-page":"2744","volume":"61","author":"C Wild-Bode","year":"2001","unstructured":"Wild-Bode, C., Weller, M., Rimner, A., Dichgans, J., & Wick, W. (2001). Sublethal irradiation promotes migration and invasiveness of glioma cells: Implications for radiotherapy of human glioblastoma. Cancer Research, 61(6), 2744\u20132750.","journal-title":"Cancer Research"},{"key":"5724_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9230647","author":"C Yang","year":"2022","unstructured":"Yang, C., Y, X., Du, Y., Xiong, J., Deng, L., Liang, Q., Yuan, J., He, C., He, F., & Huang, X. (2022). Iodine-125 seeds inhibit carcinogenesis of hepatocellular carcinoma cells by suppressing epithelial\u2013mesenchymal transition via TGF-\u03b21\/Smad signaling. Disease Markers. https:\/\/doi.org\/10.1155\/2022\/9230647","journal-title":"Disease Markers"},{"issue":"1","key":"5724_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-022-02356-0","volume":"22","author":"FLWY Gao","year":"2022","unstructured":"Gao, F. L. W. Y., Huang, X. Z., Pan, T. F., & Guo, J. H. (2022). I-125 seeds brachytherapy with transcatheter arterial chemoembolization for subcapsular hepatocellular carcinoma. BMC Gastroenterology, 22(1), Article 273.","journal-title":"BMC Gastroenterology"},{"issue":"1","key":"5724_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00018-023-05099-7","volume":"81","author":"WYL Xue","year":"2024","unstructured":"Xue, W. Y. L., Chen, C., Ashrafizadeh, M., Tian, Y., & Sun, R. (2024). Wnt\/\u03b2-catenin-driven EMT regulation in human cancers. Cellular and Molecular Life Sciences, 81(1), 79.","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"1","key":"5724_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-025-02363-1","volume":"24","author":"XQH Wu","year":"2025","unstructured":"Wu, X. Q. H., Li, Q., & Wei, X. (2025). Wnt\/\u03b2-catenin mediated signaling pathways in cancer: Recent advances and applications in cancer therapy. Molecular Cancer, 24(1), 171.","journal-title":"Molecular Cancer"},{"issue":"Suppl 1","key":"5724_CR45","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1134\/S000629792314002X","volume":"88","author":"TNPE Hasanau","year":"2023","unstructured":"Hasanau, T. N. P. E., Kisil, O. V., & Zvereva, M. E. (2023). The TERT promoter: A key player in the fight for cancer cell immortality. Biochemistry (Moscow, Russia), 88(Suppl 1), S21\u2013S38.","journal-title":"Biochemistry (Moscow, Russia)"},{"issue":"5","key":"5724_CR46","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00134-021-06394-2","volume":"47","author":"DSK Chaudhuri","year":"2021","unstructured":"Chaudhuri, D. S. K., Karkar, A., Sharif, S., Lewis, K., Mammen, M. J., Alexander, P., Ye, Z., Lozano, L. E. C., Munch, M. W., Perner, A., Du, B., Mbuagbaw, L., Alhazzani, W., Pastores, S. M., Marshall, J., Lamontagne, F., Annane, D., Meduri, G. U., & Rochwerg, B. (2021). Corticosteroids in COVID-19 and non-COVID-19 ARDS: A systematic review and meta-analysis. Intensive Care Medicine, 47(5), 521\u2013537.","journal-title":"Intensive Care Medicine"},{"issue":"7251","key":"5724_CR47","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/nature08137","volume":"460","author":"JIVA Park","year":"2009","unstructured":"Park, J. I. V. A., Hong, J. Y., Choi, J., Jun, S., Shkreli, M., Chang, W., Meng, Z., Cheung, P., Ji, H., McLaughlin, M., Veenstra, T. D., Nusse, R., McCrea, P. D., & Artandi, S. E. (2009). Telomerase modulates Wnt signalling by association with target gene chromatin. Nature, 460(7251), 66\u201372.","journal-title":"Nature"},{"issue":"20","key":"5724_CR48","first-page":"11471","volume":"15","author":"YSH Cai","year":"2023","unstructured":"Cai, Y. S. H., Song, X., Zhao, J., Xu, D., & Liu, M. (2023). The Wnt\/\u03b2-catenin signaling pathway inhibits osteoporosis by regulating the expression of TERT: An in vivo and in vitro study. Aging (Albany NY), 15(20), 11471\u201311488.","journal-title":"Aging (Albany NY)"},{"key":"5724_CR49","doi-asserted-by":"crossref","unstructured":"Behrooz, A. B. S. A. (2021). Could we address the interplay between CD133, Wnt\/\u03b2-catenin, and TERT signaling pathways as a potential target for glioblastoma therapy? Front Oncol. (11):Front Oncol.","DOI":"10.3389\/fonc.2021.642719"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05724-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05724-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05724-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:02:57Z","timestamp":1789200177000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-026-05724-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5724"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05724-8","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"2 May 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Animal Experimental Ethics Committee of the Second Affiliated Hospital of Kunming Medical University (Ethics Approval No.: ZJ20230786). All procedures were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. All procedures complied with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Zhi Zeng: declares that he\/she has no conflict of interest.Yan Li: declares that he\/she has no conflict of interest.JunFeng Ma: declares that he\/she has no conflict of interest.LiYing Dong: declares that he\/she has no conflict of interest.SiQi Li: declares that he\/she has no conflict of interest.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}